Rheumatic fever is one of the complications associated with strep throat. It occurs as a delayed sequel to group A streptococcal pharyngitis. It may affect connective tissues of the joints, heart, vessels, and skin. In developing economies, rheumatic fever is highly prevalent and remains one of the major causes of acquired cardiovascular disease. Rheumatic fever is a major cause of mortality among people aged 50 years and above. According to the United Nations Department of Economic and Social Affairs, in 2015, the global population aged 60 years and above was approximately 901 million, and the number is expected to increase significantly during the forecast period. The population aged 50 years and above has a higher incidence of rheumatic disease and mortality rates as compared to younger people. The incidence rate of rheumatic fever is higher in developing countries as compared to that in developed countries. According to the Centers for Disease Control and Prevention (CDC), about 23% of adults in the U.S., which is over 54 million people, have arthritis. By 2040, the disease is expected to affect 78 million adults in the country. Rheumatic fever is a leading cause of disability. The direct medical costs associated with the disease are over US$ 81 Mn annually. This disease is more common in women than in men.
The global rheumatic fever treatment market can be segmented based on drug class, route of administration, distribution channel, and geography. Based on drug class, the global rheumatic fever treatment market can be classified into antibiotics, disease-modifying anti-rheumatic drugs (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs), anticonvulsant medication, and others. Antibiotics are a type of medicine that helps in arresting infections caused by bacteria. They prevent the spread of bacterial infections, either by killing the bacteria or by curtailing their ability to reproduce. Disease-modifying anti-rheumatic drugs (DMARDs) is a group of medicines or a combination of medicines used to treat a rheumatic fever by blocking inflammation. Disease-modifying anti-rheumatic drugs are categorized into two major types: biologic DMARDs and synthetic DMARDs (also called traditional DMARDs). The use of biologic DMARDs is higher. Nonsteroidal anti-inflammatory drugs (NSAIDs) is a class of analgesic drugs that reduce pain and inflammation by decreasing the blood level of prostaglandins. Prostaglandins are chemicals that promote inflammation and pain. Anticonvulsants are a diverse group of pharmacological agents used in the treatment of rheumatic fever. They are also increasingly being used in the treatment of rheumatic fever.
Based on the route of administration, the global rheumatic fever treatment market can be categorized into oral, parenteral, and topical. In terms of the distribution channel, the global rheumatic fever treatment market can be segmented into retail pharmacies, hospital pharmacies, and online pharmacies. Retail pharmacies are stores where drugs are dispensed to patients. A community retail pharmacy can be an independent pharmacy, a supermarket pharmacy, a chain pharmacy, or a mass merchandiser pharmacy with a state license to dispense medications to the general public at retail prices as a pharmacy. A hospital pharmacy is a department or service in a hospital that is responsible for the supply of medicines to hospital ward patients as well as ambulatory patients. An online pharmacy, Internet pharmacy, or mail-order pharmacy is a pharmacy that operates over the Internet and delivers orders to customers through shipping companies. An increase in the preference for online purchasing is expected to boost the online pharmacies segment during the forecast period.
Based on geography, the rheumatic fever treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The rheumatic fever treatment market in North America can be segmented into the U.S. and Canada. The rheumatic fever treatment market in Europe can be segmented into the U.K., Germany, France, Italy, Spain, and Rest of Europe. The rheumatic fever treatment market in the Asia Pacific can be further segmented into China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific. The rheumatic fever treatment market in Latin America can be classified into Mexico, Brazil, and Rest of Latin America. The rheumatic fever treatment market in Middle East & Africa can be segmented into South Africa, Saudi Arabia, Israel, and Rest of Middle East & Africa. North America dominated the global rheumatic fever treatment market, owing to an increase in the geriatric population and a rise in the prevalence of rheumatic fever in the region.
Some of the major players in global rheumatic fever treatment market are Abbott, F. Hoffmann-La Roche Ltd, Novartis, Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Bayer AG, and Bausch Health Companies Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.